Davis R M Inc. Buys 13,019 Shares of Procter & Gamble Company (The) $PG

Davis R M Inc. raised its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 4.7% in the 2nd quarter, Holdings Channel reports. The firm owned 292,264 shares of the company’s stock after acquiring an additional 13,019 shares during the period. Davis R M Inc.’s holdings in Procter & Gamble were worth $46,563,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC grew its holdings in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares in the last quarter. Northern Trust Corp boosted its position in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after acquiring an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Procter & Gamble by 3.5% in the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Up 0.5%

Shares of NYSE PG opened at $146.90 on Monday. The company has a market cap of $343.28 billion, a P/E ratio of 21.45, a PEG ratio of 3.87 and a beta of 0.36. The firm has a 50-day simple moving average of $152.93 and a two-hundred day simple moving average of $157.02. Procter & Gamble Company has a 1 year low of $144.46 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same period in the prior year, the business posted $1.93 earnings per share. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s payout ratio is currently 61.61%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. BNP Paribas Exane dropped their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Morgan Stanley set a $175.00 price objective on Procter & Gamble in a research note on Monday, October 27th. Barclays lowered their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Finally, Wells Fargo & Company dropped their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. Twelve investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.53.

Read Our Latest Stock Report on Procter & Gamble

Insider Transactions at Procter & Gamble

In related news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at $8,279,007.34. This trade represents a 18.11% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the sale, the chief operating officer directly owned 28,036 shares of the company’s stock, valued at approximately $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 150,488 shares of company stock valued at $23,529,718. Company insiders own 0.20% of the company’s stock.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.